# Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC)

> clinical trial · VERIFIED · 2026-06-25

Status: RECRUITING · Sponsor: Tianjin Medical University Second Hospital · Condition: Renal Cell Carcinoma (Kidney Cancer)

- Company: Tianjin Medical University Second Hospital
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07321197

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.